Feature | May 15, 2012 | Dave Fornell

Medrad, Covidien release next generation systems

Recently Introduced  Contrast Injectors

The Bayer/Medrad Mark 7 Arterion angiographic injector is designed for better ergonomics, to be small, light-weigh and easy to use.


Two next-generation automated contrast injector systems were recently introduced in the United States. 

In March 2012, Covidien began its global launch of a new version of its Optivantage dual-head computed tomography (CT) contrast media delivery system that allows simultaneous injection. The vendor said simultaneous injection and use of prefilled syringes offer technicians flexibility. The prefilled syringes also help minimize the risk of contamination from filling empty syringes. The system offers Covidien’s Optibolus software to deliver contrast media at a decelerating exponential rate compared to the standard constant rate of uniphasic injections.

At RSNA 2011, Medrad (now Bayer) introduced the Mark 7 Arterion angiographic injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver than previous Medrad injectors. It also is easier to operate than previous models, requiring less time to position and set up. It has a clearly visible and intuitive user interface to guide the user through proper set-up, and highlights the information needed to perform injections.

The Mark 7 Arterion has a unique front loading system to simplify set-up and makes for a cleaner tear down. The Mark 7 Arterion syringe provides a clear view of the contrast. 

Bracco Acquires Swiss Medical Care

In January, Bracco Imaging SpA acquired Swiss Medical Care (SMC), a Swiss contrast injector system vendor. The acquisition is a continuation of Bracco’s expansion into the injector market, after previously purchasing Acist and EZEM. The company said Swiss Medical will further strengthen its portfolio of solutions for radiology and diagnostic imaging. Swiss Medical said the merger will help expand sales of its CT Exprés computed tomography syringe-less contrast injector, which gained U.S. Food and Drug Administration approval in December 2006.

 Connecting Injector Data to EMRs

At RSNA 2011, Medrad released the Certegra Informatics Connect.RIS vendor-neutral informatics application to establish connectivity between Medrad’s Stellant contrast-injection systems and hospital information systems.  The application auto-populates contrast-injection records into reporting systems, eliminating the need to look for or dictate contrast-injection records.


Related Content

News | Contrast Media

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
Feature | Contrast Media | By Christine Book

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

Time May 03, 2023
arrow
Sponsored Content | Videos | Contrast Media

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

Time February 27, 2023
arrow
News | Contrast Media

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time February 16, 2023
arrow
Feature | Contrast Media Injectors | By Christine Book

The vital, and growing role of contrast media, and the medical devices employed to inject the agent into the body ...

Time January 19, 2023
arrow
News | Computed Tomography (CT)

December 12, 2022 — GE Healthcare announced an agreement with ulrich medical for a GE Healthcare branded contrast media ...

Time December 12, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
News | Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
News | Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

Time July 18, 2022
arrow
Subscribe Now